| GENERIC NAME | This data is not available for free |
| INDICATION'S | HyperCholesterolemia Treat. |
| MARKETER'S COUNTRY | Europe |
| MECHANISM OF ACTION |
- Cholesterol Absorption Inh. (Ezetimibe) - Cholesterol BioSynthesis Inh. (SimvaStatin) - (B): BioSynthesis Inhibition |
| STATUS | US Patent Expiration Date: 10.14.2017 |
| COMPANY | This data is not available for free |
| PATENT NUMBER | This data is not available for free |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |